Yoshiji Fujita

Locality: Japan
Summary: Owner, CytoPathfinder Inc.
Current: Owner at CytoPathfinder Inc.
Industry: Biotechnology
Experience: CytoPathfinder Inc. (Biotechnology industry): Owner,   

A new approach to pharmacogenomics. Yoshiji FUJITA Research Division, Glaxo Wellcome K.K., Ibaraki ３００‐４２４７, Japan Abstract: The medicine in the ２１st century will ...

Dr. Yoshiji Fujita, Tokyo Medical College Dr. Osamu Nagayama, Chugai Pharmaceuticals (Tentative) Possibility of regenerative medicine with brain neural stem ...

Yoshiji Fujita (Tokyo Medical University, Tokyo) Proteome analysis of anticancer drug response. 14:3014:40. Discussion. 14:4015:00. Coffee Break

A NOVEL ETHYNYLATION OF -SUBSTITUTED MESITYL OXIDES : Yoshiji Fujita, Fumio Wada, Takashi Onishi and Takashi Nishida [Full Text PDF]

SELECTIVE ISOMERIZATION OF 2,5-DIENONES TO 2,4-DIENONES WITH NICKEL ACETYLACETONATE CATALYST : Takashi Onishi, Yoshiji Fujita and Takashi Nishida

Toshio Tanaka and Yoshiji Fujita ..... 17P. S9 Animal models of ocular disease for drug development Kazutaka Momose and Hajime Yasuhara ..... 18P

A CONVENIENT SYNTHESIS OF A KEY INTERMEDIATE OF ALPHA-TOCOPHEROL : Yoshiji Fujita, Manzo Shiono, Katsushi Ejiri and Kazumi Saita [Full Text PDF]

chaired by Richard J. Simpson and Yoshiji Fujita. Toru Natsume, National Inst of Advanced Industrial Science and Technology, Tokyo (014) Systematic analysis of protein ...

A FACILE SYNTHESIS OF 4-HYDROXYINDOLE VIA ELECTROCHEMICAL OXIDATIVE CC COUPLING : Sigeru Torii, Kenji Uneyama, Takashi Onishi, Yoshiji Fujita, Michihiro Ishiguro and ...

Yoshiji Fujita, Ph.D. (President & CEO) Alun McCarthy, Ph.D. (Managing Director) Naoto Kagiyama, Ph.D. Fumiko Yoshii; Hideki Kagami, MBA; Kazuyuki Masuda, MBA, Ph.D.

Ｃｙｔｏ Pathfinder Agreement Concerning Joint Research of Ophthalmic drug March 22,2006—CytoPathfinder, Inc.(headquartered in Tokyo, Shinagawa, Japan, CEO: Yoshiji Fujita) and ...

Yoshiji Fujita, PhD CytoPathfinder Inc. President & CEO: Summary: Key factors to succeed in industrializing a cutting edge technology within its limited life-cycle are "Speed" and ...